Table 1 Participant demographic characteristics by treatment group

From: Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial

 

RC14-GR1

LGG-BB12

RC14-GR1

No RC14-GR1

LGG-BB12

No LGG-BB12

n (%)

n (%)

n (%)

n (%)

Characteristics

N

101

106

104

103

Participant location at recruitment

     

  Inpatient

 

19(19)

21(20)

22(21)

18(17)

  Outpatient

 

82 (81)

85(80)

82(79)

85(83)

Gender

     

  Female

 

18(18)

26(25)

18(17)

26(25)

  Male

 

83(82)

80(75)

86(83)

77(75)

Bladder management

     

  Indwelling catheter

 

9(9)

12(12)

12(12)

9(8)

  Suprapubic catheter

 

51(50)

51(48)

49(47)

53(51)

  Clean intermittent catheters

 

34(34)

37(35)

38(36)

33(32)

  Reflex voiding (±condom)

 

7(7)

6(5)

5(5)

8(8)

Level of injury

     

  Cervical

 

46(45)

51(48)

48(46)

49(44)

  Thoracic

 

43(43)

50(47)

48(46)

45(47)

  Lumbar

 

12(12)

5(5)

8(8)

9(9)

Completeness of injury a

     

  Complete

 

53(52)

53(50)

55(53)

51(50)

  Incomplete

 

48(48)

53(50)

49(47)

52(50)

Presence of urinary stone

     

  None

 

98(97)

98(92)

97(93)

99(96)

  Present

 

3(3)

8(8)

7(7)

4(4)

Age (years)

     

  <25

 

6 (6)

9(8)

8(8)

7(7)

  25 to <45

 

33(33)

34(32)

37(36)

30(29)

  45 to <65

 

48(47)

43(41)

44(42)

47(46)

  >65

 

14(14)

20(19)

15(14)

19(18)

Time since injury

     

  <2 years

 

27(27)

30(28)

29(28)

28(27)

  2–20 years

 

52(51)

43(41)

48(46)

47(46)

  >20 years

 

22 (22)

33(31)

27(26)

28(27)

AIS classification a

     

  A

 

53(52)

53(50)

55(53)

51(50)

  B

 

17(17)

19(18)

22(21)

14(14)

  C

 

14(14)

19(18)

14(13)

19(18)

  D

 

17(17)

15(14)

13(13)

19(18)

  E

 

0

0

0

0

Urinary tract infection in the last 6 months prior to trial

     

  0

 

38(37)

44(41)

49(47)

33(32)

  1

 

31(31)

23(22)

19(18)

35(34)

  2 to 5

 

26(26)

33(31)

32(31)

27(26)

  More than 5

 

6(6)

6(6)

4(4)

8(8)

Hospitalisation prior to trial in last 6 months

     

  0

 

91(90)

91(86)

91(87)

91(88)

  1

 

8(8)

12(11)

9(9)

11(11)

  2–5

 

1(1)

3(3)

3(3)

1(1)

  More than 5

 

1(1)

0

1(1)

0

General practitioner visit for urinary tract infection before trial

     

  None

 

60(59)

65(61)

69(66)

56(54)

  1

 

22(22)

12(11)

10(10)

24(23)

  2–5

 

13(13)

26(25)

19(18)

20(20)

  5 or more

 

6(6)

3(3)

6(6)

3(3)

  1. aAmerican Spinal Injuries Association (ASIA) Impairment Scale (AIS) for neurological classification of SCI definition [16]